Acknowledgements.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 6, p. 313, doi. 10.1177/2040620715617056
- Publication type:
- Article
Works matching IS 20406207 AND DT 2015 AND VI 6 AND IP 6
Results: 5
1
2
The evolving role of biosimilars in haematology–oncology: a practical perspective.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 6, p. 267, doi. 10.1177/2040620715613715
- By:
- Publication type:
- Article
3
Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database.
- Published in:
- 2015
- By:
- Publication type:
- Letter
4
Recent advances in the development of Aurora kinases inhibitors in hematological malignancies.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 6, p. 282, doi. 10.1177/2040620715607415
- By:
- Publication type:
- Article
5
Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 6, p. 295, doi. 10.1177/2040620715594736
- By:
- Publication type:
- Article